RESUMO
AIM: The Severe Impairment Battery (SIB), a reliable cognitive measure for evaluating treatment response in advanced Alzheimer's disease (AD), takes approximately 20 min to administer. A recently derived 8-item version of the SIB - the SIB-8 - which takes about 3 min to administer, may represent a more convenient tool for use in clinical practice. The current analyses further explored the SIB-8 scale with respect to its validity and sensitivity. METHODS: A post hoc analysis was performed using data from a 24-week trial of donepezil 23 mg/day and 10 mg/day in > 1400 patients with moderate to severe AD [baseline Mini-Mental State Examination (MMSE) score 0-20]. Treatment effects on cognition (patterns of score change) were assessed using the full SIB and SIB-8 in the total study population and subgroups based on concomitant memantine use and baseline MMSE. Internal consistency/agreement and correlations between the SIB and SIB-8 and other clinical end points were evaluated. RESULTS: Assessment of score changes from baseline to week 24 with donepezil (23 or 10 mg/day) demonstrated comparable patterns of change when using the SIB-8 and the full SIB, despite inherent differences in the total score ranges for the two scales. Internal consistency/agreement between the full SIB and SIB-8 was good (Cronbach's alphas: 0.77-0.95). SIB-8 scores reliably correlated with SIB total scores (r = 0.859, baseline; r = 0.900, week 24; p < 0.0001), as well as MMSE scores (r = 0.7163, baseline; r = 0.7963, week 24; p < 0.0001). Scores on both SIB scales were moderately associated with functional measures at baseline and week 24. CONCLUSIONS: In this post hoc analysis, similar treatment effects were measured by the full SIB and the SIB-8. Very good internal consistency/agreement and strong correlations between the SIB and the more rapid and convenient SIB-8 indicate that the SIB-8 may be a useful and efficient clinical proxy for the full SIB in evaluating treatment response in patients with advanced AD.
Assuntos
Doença de Alzheimer/tratamento farmacológico , Indanos/administração & dosagem , Testes Neuropsicológicos/normas , Nootrópicos/administração & dosagem , Piperidinas/administração & dosagem , Atividades Cotidianas , Análise de Variância , Transtornos Cognitivos/diagnóstico , Donepezila , Método Duplo-Cego , Humanos , Índice de Gravidade de Doença , Resultado do TratamentoRESUMO
A new phenomenon is reported in which alternate stimulation of either nasal or temporal hemiretinas produces, respectively, apparent oscillation in depth either behind or ahead of the frontal plane. This control over the perceived movement is dependent on the proper positioning of stimuli presented interocularly and in horizontal arrangements.
Assuntos
Percepção de Profundidade , Percepção de Movimento , Adolescente , Adulto , Movimentos Oculares , Humanos , Retina/fisiologia , Testes Visuais , Campos VisuaisRESUMO
An extensive literature reports changes in quantitative electroencephalogram (QEEG) with aging and a relationship between magnitude of changes and degree of clinical deterioration in progressive dementia. Longitudinal studies have demonstrated QEEG differences between mild cognitively impaired (MCI) elderly who go on to decline and those who do not. This study focuses on normal elderly with subjective cognitive complaints to assess the utility of QEEG in predicting future decline within 7 years. Forty-four normal elderly received extensive clinical, neurocognitive and QEEG examinations at baseline. All study subjects (N = 44) had only subjective complaints but no objective evidence of cognitive deficit (evaluated using the Global Deterioration Scale [GDS] score, GDS stage = 2) at baseline and were re-evaluated during 7-9 year follow-up. Baseline QEEGs of Decliners differed significantly (p < 0.0001, by MANOVA) from Non-Decliners, characterized by increases in theta power, slowing of mean frequency, and changes in covariance among regions, especially on the right hemisphere. Using logistic regression, an R2 of 0.93 (p < 0.001) was obtained between baseline QEEG features and probability of future decline, with an overall predictive accuracy of 90%. These data indicate high sensitivity and specificity for baseline QEEG as a differential predictor of future cognitive state in normal, subjectively impaired elderly.
Assuntos
Transtornos Cognitivos/classificação , Transtornos Cognitivos/diagnóstico , Diagnóstico por Computador/métodos , Eletroencefalografia/métodos , Índice de Gravidade de Doença , Idoso , Eletrofisiologia/métodos , Feminino , Humanos , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Valores de Referência , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
Six female outpatients with Alzheimer's disease (AD) along with four female controls of a similar age range were analyzed for sister chromatid exchangers (SCEs), cell cycle kinetics, and sensitivity to mutagens, in lymphocyte cultures. The mean level of SCEs for the AD patients was 11.40 SCEs/metaphase, while that for the controls was 9.12. The difference between the two groups was significant as shown by the Wilcoxon rank-sum test (p = 0.05). Cell cycle was 50% longer both in the AD patients (31.7 hr) and aged controls (31.5 hr) than in normal young adults (21.76 hr). Mitomycin-C (MMC) decreased the mitotic index in AD patients by 35% and in controls by only 12%. MMC also increased the cell cycle duration in AD patients by a greater extent (20%) than it did in the controls (13.5%), and AD cells were more sensitive to the toxic effects of bromodeoxyuridine. What appeared to be chromosomes with prematurely divided centromeres were also observed in AD cells.
Assuntos
Doença de Alzheimer/genética , Ciclo Celular , Troca Genética , Troca de Cromátide Irmã , Idoso , Bromodesoxiuridina/administração & dosagem , Ciclo Celular/efeitos dos fármacos , Aberrações Cromossômicas , Troca Genética/efeitos dos fármacos , Feminino , Humanos , Cariotipagem , Leucócitos/citologia , Pessoa de Meia-Idade , Mitomicina , Mitomicinas/farmacologia , Índice Mitótico , Mutação , Troca de Cromátide Irmã/efeitos dos fármacosRESUMO
Elderly controls and probable Alzheimer's disease patients underwent serial positron emission tomography (PET) studies during a baseline condition and while performing a verbal memory task. For the temporal lobes, all 7 Alzheimer patients demonstrated a relative shift in glucose metabolic rates to the right hemisphere during the memory condition relative to baseline, and 5 of 7 controls showed a shift to the left hemisphere. Baseline absolute regional metabolic rates replicate previous findings and were somewhat less useful than the memory challenge in differentiating patients from controls. These results indicate that a temporal lobe abnormality in Alzheimer's disease is related to memory performance.
Assuntos
Doença de Alzheimer/fisiopatologia , Lobo Temporal/fisiopatologia , Tomografia Computadorizada de Emissão , Idoso , Doença de Alzheimer/diagnóstico , Doença de Alzheimer/psicologia , Análise de Variância , Radioisótopos de Carbono , Cognição , Desoxiglucose , Glucose/metabolismo , Humanos , Memória , Pessoa de Meia-IdadeRESUMO
Young normal subjects, old normal subjects, and patients with senile dementia of the Alzheimer's type (SDAT) were studied with both computed tomography (CT) and positron emission transaxial tomography (PETT). Increases in ventricular size with both aging and disease were measured. Regional glucose metabolic rate was not affected by age, but was markedly reduced in SDAT patients. These data indicate that in normal aging, structural brain changes may be more salient than biochemical changes. Although both structural and biochemical changes occur in SDAT, the biochemical changes are more marked. The results suggest that PETT is potentially more useful than CT in the in vivo diagnosis of SDAT.
Assuntos
Envelhecimento , Doença de Alzheimer/diagnóstico por imagem , Demência/diagnóstico por imagem , Tomografia Computadorizada de Emissão , Tomografia Computadorizada por Raios X , Adulto , Idoso , Doença de Alzheimer/psicologia , Cognição , HumanosRESUMO
In two experiments, a total of 20 young normals, 29 elderly normals, and 76 elderly demented subjects were administered a computerized delayed visuospatial recall task. Subjects were instructed to remember which room of a 25-room house had a light on in the window. A choice reaction time task was interposed during the delay interval (0-120 seconds) between stimulus presentation and recall. The test was designed to be (1) face valid-relevant to the subjects' everyday lives, (2) sensitive and specific to the cognitive decline associated with senile dementia of the Alzheimer's type (SDAT), and (3) comparable to animal memory tests. Immediate recall of the spatial location of a single stimulus was found to be deficient in severely demented subjects only, and all groups exhibited a decline in recall accuracy with increasing delay intervals. This decline in recall accuracy was greatest in severely demented subjects, smaller in less demented subjects, still smaller in aged normals, and smallest in young normals. No significant forgetting of spatial location occurred between 30 and 120 seconds after stimulus presentation. Increasing stimulus number decreased recall accuracy in all groups and the elderly and elderly demented subjects were more sensitive to the increase in stimulus load than the young normals. Choice reaction time also proved sensitive to age and severity of dementia. Correlation analyses demonstrated that delayed spatial recall (as well as choice reaction time) is highly correlated with clinically evaluated global cognitive status, as well as with tests of verbal recall.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Demência/psicologia , Memória , Rememoração Mental , Percepção Espacial , Percepção Visual , Adolescente , Adulto , Fatores Etários , Idoso , Atenção , Transtornos Cognitivos/psicologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Orientação , Testes Psicológicos , Tempo de Reação , Retenção PsicológicaRESUMO
Levels of the amine metabolites homovanillic acid (HVA) and methoxyhydroxyphenylglycol (MHPG) were measured in the cerebrospinal (CSF) fluid of drug-free patients with Alzheimer's disease and compared to levels in a group of controls. No significant differences were found in CSF HVA and MHPG, although the Alzheimer's group was severely demented. Platelet monoamine oxidase (MAO) enzyme kinetics were measured and did not differ between controls and Alzheimer patients. The degree of dementia did not show any significant correlation with the levels of HVA or MHPG. It was concluded that, unlike previous reports in the literature, the dementia of Alzheimer's disease was not related to changes in central catecholamine metabolism nor was it associated with increased platelet MAO activity.
Assuntos
Doença de Alzheimer/líquido cefalorraquidiano , Transtornos Cognitivos/líquido cefalorraquidiano , Demência/líquido cefalorraquidiano , Glicóis/líquido cefalorraquidiano , Ácido Homovanílico/líquido cefalorraquidiano , Metoxi-Hidroxifenilglicol/líquido cefalorraquidiano , Fenilacetatos/líquido cefalorraquidiano , Idoso , Doença de Alzheimer/psicologia , Plaquetas/enzimologia , Transtornos Cognitivos/psicologia , Humanos , Pessoa de Meia-Idade , Monoaminoxidase/sangue , Tomografia Computadorizada por Raios XRESUMO
Although it is generally held that about 10% of the population is left-handed, reported figures vary widely due to differences in handedness classification criteria and subject characteristics. Among those population studies that have used the same handedness classification criteria, a consistent relationship between increasing right-hand preference and increasing age has been reported. One recent study of Alzheimer's disease (AD) reported a higher incidence of left-handedness in early onset relative to late onset cases. In the present study we examined handedness patterns in three elderly groups; normal (N = 217), depression (N = 73), and AD (N = 114). Our results indicated a reduced frequency of left handedness in AD (2.6%) relative to control (11.1%) and depression (13.7%) groups. Within the limited age range we studied (60-80 years), no relationships were found between age and handedness preference either within or across the groups. Furthermore, for the AD group there was no relationship between severity of global impairment and strength of handedness. Our results suggest that compared to right handers, left handers are less vulnerable to the cognitive changes associated with AD. Nevertheless it is also possible that left handers are overrepresented among early onset dementia patients and die before entering the pool of senile dementia patients. Further work is required to determine if early and late onset AD are associated with different incidences of left handedness.
Assuntos
Doença de Alzheimer/psicologia , Lateralidade Funcional , Idoso , Doença de Alzheimer/epidemiologia , Humanos , Pessoa de Meia-IdadeRESUMO
We report on the quantitative analysis of the EEG (QEEG), using the Neurometric method, in large samples of normal elderly; normal subjectively impaired elderly; patients with mild cognitive impairment; patients presenting with a continuum of primary cognitive deterioration from mild to moderately severe as measured by the Global Deterioration Scale (GDS), compatible with dementia of the Alzheimer's type (DAT). Neurometric QEEG measures were found to be a sensitive index of degree of cognitive impairment, especially reflected in increased absolute and relative power in the theta band, with delta increasing in later stages of deterioration. While these abnormalities were widespread, neither localized or lateralized, MANOVA's for GDS and relative power in theta reached highest significance in a bilateral temporo-parietal arc. A possible relationship between hippocampal dysfunction, cognitive deterioration, and theta abnormalities is discussed in relation to these findings. The results suggest that Neurometric QEEG features are sensitive to the earliest presence of subjective cognitive dysfunction and might be useful in the initial evaluation of patients with suspected dementia, as well as in estimating the degree of cognitive deterioration in DAT patients.
Assuntos
Transtornos Cognitivos/fisiopatologia , Eletroencefalografia , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/fisiopatologia , Doença de Alzheimer/psicologia , Mapeamento Encefálico , Transtornos Cognitivos/psicologia , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Neuropathological investigations have demonstrated brain-behavior relationships in senile dementia of the Alzheimer's type (SDAT), but CT studies have not produced consistent findings. We hypothesized that these discouraging results were in part due to limitations in the methods of CT scan evaluations, and to non-homogeneity of patient populations. The present study examined 43 out-patients with the presumptive diagnosis of SDAT using 37 cognitive test measures and 3 independent CT evaluation strategies. The CT methods included a new rank ordering procedure and two previously used techniques, physical measurement and 4-point rating. Highly significant (p less than or equal to 0.01) brain-behavior correlations were attained using the ranking and rating procedures for evaluation of ventricular and cortical pathology. It was found that rank ordering has high interrater reliability and is superior to the other methods for the evaluation of the ventricular system. The physical measurement of the third ventricle is the single most powerful linear correlate of cognitive impairment. Measurement of cortical sulci are of no correlational significance. Multiple regression analyses indicated that global assessments are the best cognitive predictors of both ventricular and cortical pathology. Thus the present study has demonstrated brain-behavior relationships in vivo in SDAT.
Assuntos
Doença de Alzheimer/diagnóstico por imagem , Córtex Cerebral/patologia , Transtornos Cognitivos/diagnóstico , Demência/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Idoso , Doença de Alzheimer/psicologia , Atrofia , Humanos , Rememoração Mental/fisiologia , Pessoa de Meia-Idade , Destreza Motora/fisiologia , Orientação/fisiologia , Reconhecimento Visual de Modelos/fisiologia , Tempo de Reação/fisiologiaRESUMO
Using PET VI and 11-CDG we replicated our earlier PET III and 18-FDG normal aging findings. Examination of young and old normal volunteers revealed the absence of any absolute regional age-related changes in glucose utilization. For the combined sample (N = 81) we did find evidence to suggest a relative hypofrontal change with increasing age. A strong relationship between age and ventricular size (CT) was also found. These findings suggest the preserved glucose metabolism of the resting aging brain in the presence of structural atrophic changes.
Assuntos
Envelhecimento/metabolismo , Encéfalo/metabolismo , Glucose/metabolismo , Tomografia Computadorizada de Emissão , Adulto , Idoso , Envelhecimento/patologia , Atrofia , Encéfalo/patologia , Ventriculografia Cerebral , Desoxiglucose/análogos & derivados , Fluordesoxiglucose F18 , Humanos , Pessoa de Meia-IdadeRESUMO
(18)F-2-deoxy-2-fluoro-D-glucose ((18)FDG) is a positron emitting tracer for rate of glucose utilization in brain. When used in conjunction with positron emission tomography (PET), the PET-FDG technique permits in vivo quantitation of regional brain metabolism in man. We have applied this technique to the study of regional brain function in normal aging and senile dementia. Preliminary results for 7 patients with senile dementia of the Alzheimer's type (SDAT) and 3 elderly normal subjects indicated a large, statistically significant (p < 0.01) diminution in rate of glucose utilization in SDAT. Furthermore, the degree of diminution in metabolic activity in SDAT was highly correlated with objective measures of degree of cognitive impairment. These results demonstrate the feasibility and potential utility of the PET-FDG technique for studying regional brain function in normal aging and dementia.
RESUMO
We used CT and MR to examine the frequency of occurrence of hippocampal formation atrophy (HA) in a research clinic population of 130 normal elderly, 72 nondemented patients with very mild memory and cognitive impairments (MCI), 73 mild Alzheimer's disease (AD) patients, and 130 patients with moderate to severe AD. HA was found in 29% of the normal elderly group and its frequency of occurrence was strongly related to increasing age. For normal elderly 60-75 years of age, 15% had HA: the proportion rose to 48% in subjects 76-90 years of age. Among the three groups of impaired patients, the frequencies of HA ranged from 78% in the MCI patients to 96% in the advanced AD group. Unlike the normal elderly group, the percentages were not related to age. In both the normal elderly group and MCI group disproportionately more males than females had HA. After controlling for learning and the effects of generalized brain changes as reflected in ventricular size, only in the normal group was HA associated with reduced delayed verbal recall performance. Follow-up examinations for 15 individuals with baseline HA. 4 who at entry were MCI and 11 probable AD, yielded clinical and neuropathologic diagnoses of AD in all cases. The results of the present study indicate that hippocampal formation atrophy is associated with memory and cognitive impairments. Further longitudinal and neuropathologic work is required to validate the relationship between hippocampal formation atrophy and AD.
Assuntos
Envelhecimento/patologia , Doença de Alzheimer/patologia , Hipocampo/patologia , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/diagnóstico por imagem , Atrofia , Ventrículos Cerebrais/patologia , Ventriculografia Cerebral , Estudos Transversais , Feminino , Lateralidade Funcional/fisiologia , Hipocampo/diagnóstico por imagem , Humanos , Imageamento por Ressonância Magnética , Masculino , Memória/fisiologia , Pessoa de Meia-Idade , Psicometria , Caracteres Sexuais , Tomografia Computadorizada por Raios XRESUMO
The most widely known substances that have been investigated for treating cognitive deterioration in the aged are cerebral vasodilators, Gerovital H3, psychostimulants, "nootropics," neuropeptides, and neurotransmitters. The rationale for the choice of specific agents has shifted as our conceptions regarding the origins of cognitive decline have changed; we now know that most cognitive deterioration occurs independently of arteriosclerotic vascular changes. Substances currently being investigated because of their effects on brain electrophysiology, on neurohumoral processes, or on central neurotransmitters show promise.
Assuntos
Transtornos Cognitivos/tratamento farmacológico , Anticoagulantes/uso terapêutico , Ensaios Clínicos como Assunto , Di-Hidroergotoxina/uso terapêutico , Humanos , Oxigenoterapia Hiperbárica , Metilfenidato/uso terapêutico , Parassimpatomiméticos/uso terapêutico , Peptídeos/uso terapêutico , Piracetam/uso terapêutico , Procaína/uso terapêutico , Vasodilatadores/uso terapêuticoRESUMO
In a double-blind trial, 12 patients with probable Alzheimer's disease were treated for 6 weeks with placebo and 6 weeks with monosialoganglioside (GM1) (100 mg/day i.m.), which potentiates the actions of nerve growth factor. GM1 failed to produce significant improvement in patients' cognitive test performance, suggesting that this is not a viable approach to the treatment of cognitive deterioration in Alzheimer's disease.
Assuntos
Doença de Alzheimer/tratamento farmacológico , Gangliosídeos/uso terapêutico , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/diagnóstico , Doença de Alzheimer/psicologia , Pressão Sanguínea/efeitos dos fármacos , Método Duplo-Cego , Esquema de Medicação , Feminino , Gangliosídeos/efeitos adversos , Gangliosídeos/farmacologia , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Crescimento Neural/fisiologia , Testes Neuropsicológicos , Placebos , Estimulação Química , Resultado do TratamentoRESUMO
Cognitive decline associated with old age and consistent with the diagnosis of primary degenerative dementia is a unique clinical syndrome with characteristic phenomena and progression. The authors describe a Global Deterioration Scale for the assessment of primary degenerative dementia and delineation of its stages. The authors have used the Global Deterioration Scale successfully for more than 5 years and have validated it against behavioral, neuroanatomic, and neurophysiologic measures in patients with primary degenerative dementia.
Assuntos
Doença de Alzheimer/diagnóstico , Demência/diagnóstico , Escalas de Graduação Psiquiátrica , Doença de Alzheimer/classificação , Doença de Alzheimer/psicologia , Transtornos Cognitivos/classificação , Transtornos Cognitivos/diagnóstico , Transtornos Cognitivos/psicologia , Estudos de Avaliação como Assunto , Humanos , Testes Psicológicos , PsicometriaRESUMO
The authors examined three groups of children for minor physical anomalies: 52 autistic children, 34 nonautistic siblings of these patients, and 29 normal controls. The total number of anomalies and the weighted score were significantly higher in the autistic children. The formation of these anomalies in the first three months of fetal life may concur with the developmental deviation of the central nervous system in some of these individuals.
Assuntos
Anormalidades Múltiplas/genética , Esquizofrenia Infantil/complicações , Anormalidades Múltiplas/epidemiologia , Adolescente , Transtorno Autístico/complicações , Transtorno Autístico/genética , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Gravidez , Complicações na Gravidez/epidemiologia , Primeiro Trimestre da Gravidez , Esquizofrenia Infantil/genéticaRESUMO
OBJECTIVE: To estimate the prevalence of radiographically detectable hippocampal atrophy (HA) in a normal aging sample and to test whether such atrophy is associated with memory dysfunction. DESIGN: One hundred fifty-four medically healthy and cognitively normal elderly persons (aged 55 to 88 years) received magnetic resonance imaging and/or computed tomographic scans designed to identify HA. One hundred forty-five of these subjects also underwent psychometric tests of memory function. Multivariate analyses of variance were used to evaluate differences in memory performance between subjects with and without HA. SETTING: This study was conducted at a research clinic for the investigation of age-associated neuropsychological and neuroradiologic changes. PARTICIPANTS: Based on the following criteria, 154 subjects were consecutively selected from a larger group of elderly research volunteers participating in a study of normal aging: age of 55 years or greater; Global Deterioration Scale score of 2 or less; and Mini-Mental State examination score of 28 or greater. Subjects with evidence for significant medical, psychiatric, or neurologic disease were excluded. MAIN OUTCOME MEASURES: Outcome measurements included individual psychometric test scores and computed tomographic-magnetic resonance imaging hippocampal atrophy ratings. RESULTS: Nearly 33% of the subjects had radiographic evidence for HA. The prevalence of HA increased significantly with age and was more common in male than female subjects. After controlling for age, level of education, and vocabulary, subjects with HA were found to perform more poorly on tests of recent (secondary) verbal memory when compared with subjects without HA (P < .01). No significant differences were found for tests of immediate (primary) memory. CONCLUSION: We conclude that HA is a common accompaniment of normal aging and is associated with mild memory impairment. Additional research is needed to determine whether HA constitutes a significant risk for future dementia.
Assuntos
Envelhecimento/patologia , Envelhecimento/psicologia , Hipocampo/diagnóstico por imagem , Hipocampo/patologia , Transtornos da Memória/patologia , Idoso , Atrofia , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Caracteres Sexuais , Tomografia Computadorizada por Raios XRESUMO
Positron emission tomographic studies of cerebral glucose metabolism have shown high diagnostic specificity in distinguishing among the degenerative dementias and differentiating between Alzheimer's disease (AD) and normal aging. The current investigation was undertaken to characterize the regional glucose metabolic deficits in AD, using cross-sectional and longitudinal study designs. All subjects met the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria for AD (n = 45) or were normal (n = 20), and the AD subjects were subdivided into incipient and mild AD and moderate plus moderately severe subgroups based on the Global Deterioration Scale. The subjects underwent a non-contrast computed tomographic scan and a positron emission tomographic (PETT VI) scan. The AD subjects (n = 14) and normal control subjects (n = 15) received evaluations 2 to 3 years after baseline study. The brain regions that show glucose metabolic deficits cross-sectionally (temporal and parietal association areas, with lesser degrees of deficit in subcortical gray matter structures), over the stages of AD, also show further deficits longitudinally within the same AD subjects. The reduction in glucose metabolism is greater than would be expected from the degree of brain atrophy. The glucose metabolic deficits are discussed in the context of neuropathologic findings and neurotransmitter deficits in AD.